BioPlus Acquisition (BioPlus Acquisition) Debt-to-Revenue : N/A (As of Jun. 2023)

View and export this data going back to 2022. Start your Free Trial

What is BioPlus Acquisition Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

BioPlus Acquisition's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was $0.25 Mil. BioPlus Acquisition's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was $5.00 Mil. BioPlus Acquisition's annualized Revenue for the quarter that ended in Jun. 2023 was $0.00 Mil.

BioPlus Acquisition Debt-to-Revenue Historical Data

The historical data trend for BioPlus Acquisition's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioPlus Acquisition Debt-to-Revenue Chart

BioPlus Acquisition Annual Data

Trend

Dec21

Dec22

Debt-to-Revenue

N/A

BioPlus Acquisition Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Debt-to-Revenue	Get a 7-Day Free Trial					N/A	N/A	N/A	N/A	N/A

Competitive Comparison of BioPlus Acquisition's Debt-to-Revenue

For the Shell Companies subindustry, BioPlus Acquisition's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioPlus Acquisition's Debt-to-Revenue Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, BioPlus Acquisition's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where BioPlus Acquisition's Debt-to-Revenue falls into.

BioPlus Acquisition Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

BioPlus Acquisition's Debt-to-Revenue for the fiscal year that ended in Dec. 2022 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0	+	5)	/	N/A
	=	N/A

BioPlus Acquisition's annualized Debt-to-Revenue for the quarter that ended in Jun. 2023 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0.25	+	5)	/	0
	=	N/A

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Jun. 2023) Revenue data.

BioPlus Acquisition Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of BioPlus Acquisition's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.